Boron-based 4-hydroxytamoxifen bioisosteres for treatment of de novo tamoxifen resistant breast cancer

ACS Medicinal Chemistry Letters

Volumn 3, Issue 5, 2012, Pages 392-396

  Jiang, Quan ^a   Zhong, Qiu ^a   Zhang, Qiang ^a   Zheng, Shilong ^a   Wang, Guangdi ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFIMOXIFENE; BORON; CYTOCHROME P450 2D6; ESTROGEN RECEPTOR; FULVESTRANT; TAMOXIFEN;

ALKYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; GENETIC POLYMORPHISM; GROWTH INHIBITION; PRIORITY JOURNAL;

EID: 84861033311     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml3000287     Document Type: Article

References (28)

1. Harvey, J. M.; Clark, G. M.; Osborne, C. K.; Allred, D. C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J. Clin. Oncol. 1999, 17, 1474
2. Musgrove, E. A.; Sutherland, R. L. Biological determinants of endocrine resistance in breast cancer Nat. Rev. Cancer 2009, 9, 631-643
3. Hoskins, J. M.; Carey, L. A.; McLeod, H. L. CYP2D6 and tamoxifen: DNA matters in breast cancer Nat. Rev. Cancer 2009, 9, 576-586
4. Bijl, M.; van Schaik, R.; Lammers, L.; Hofman, A.; Vulto, A.; van Gelder, T.; Stricker, B.; Visser, L. The CYP2D6 4 polymorphism affects breast cancer survival in tamoxifen users Breast Cancer Res. Treat. 2009, 118, 125-130
5. Jordan, V. C.; Collins, M. M.; Rowsby, L.; Prestwich, G. A Monohydroxylated metabolite of tamoxifen with potent antiestrogenic activity J. Endocrinol. 1977, 75, 305-316 (Pubitemid 8219148)
6. Jordan, V. C. Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance Breast Cancer Res. Treat. 1982, 2, 123-138 (Pubitemid 13233530)
7. Robertson, D. W.; Katzenellenbogen, J. A.; Long, D. J.; Rorke, E. A.; Katzenellenbogen, B. S. Tamoxifen antiestrogens. a comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans Isomers of tamoxifen J. Steroid Biochem. 1982, 16, 1-13 (Pubitemid 12158097)
8. Coezy, E.; Borgna, J.-L.; Rochefort, H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth Cancer Res. 1982, 42, 317-323 (Pubitemid 12207285)
9. Furr, B. J. A.; Jordan, V. C. The pharmacology and clinical uses of tamoxifen Pharmacol. Ther. 1984, 25, 127-205 (Pubitemid 14015738)
10. Desta, Z.; Ward, B. A.; Soukhova, N. V.; Flockhart, D. A. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6 J. Pharmacol. Exp. Ther. 2004, 310, 1062-1075 (Pubitemid 39108928)
11. Pujol, H.; Girault, J.; Rouanet, P.; Fournier, S.; Grenier, J.; Simony, J.; Fourtillan, J.-B.; Pujol, J.-L. Phase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue Cancer Chemother. Pharmacol. 1995, 36, 493-498
12. Rouanet, P.; Linares-Cruz, G.; Dravet, F.; Poujol, S.; Gourgou, S.; Simony-Lafontaine, J.; Grenier, J.; Kramar, A.; Girault, J.; Le Nestour, E.; Maudelonde, T. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: A prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen J. Clin. Oncol. 2005, 23, 2980-2987 (Pubitemid 46224117)
13. Mansel, R.; Goyal, A.; Nestour, E.; Masini-Etévé, V.; O'Connell, K. A phase II trial of afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women Breast Cancer Res. Treat. 2007, 106, 389-397 (Pubitemid 350029684)
14. Wu, X.; Hawse, J. R.; Subramaniam, M.; Goetz, M. P.; Ingle, J. N.; Spelsberg, T. C. The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor α for degradation in breast cancer cells Cancer Res. 2009, 69, 1722-1727
15. Ahmad, A.; Ali, S.; Ahmad, M.; Sheikh, S.; Ahmad, I. Orally administered endoxifen is a new therapeutic agent for breast cancer Breast Cancer Res. Treat. 2010, 122, 579-584
16. Trippier, P. C.; McGuigan, C. Boronic acids in medicinal chemistry: Anticancer, antibacterial and antiviral applications Med. Chem. Commun. 2010, 1, 183-198
17. Ainley, A. D.; Challenger, F. Studies of the boron-carbon linkage. Part I. The oxidation and nitration of phenylboric acid J. Chem. Soc. 1930, 2171-2180
18. Kuivila, H. G.; Armour, A. G. Electrophilic displacement reactions. ix. effects of substituents on rates of reactions between hydrogen peroxide and benzeneboronic acid J. Am. Chem. Soc. 1957, 79, 5659-5662
19. Chang, M. C.; Pralle, A.; Isacoff, E. Y.; Chang, C. J. A selective, cell-permeable optical probe for hydrogen peroxide in living cells J. Am. Chem. Soc. 2004, 126, 15392-3 (Pubitemid 39577468)
20. Du, L.; Li, M.; Zheng, S.; Wang, B. Rational design of a fluorescent hydrogen peroxide probe based on the umbelliferone fluorophore Tetrahedron Lett. 2008, 49, 3045-3048
21. Szatrowski, T. P.; Nathan, C. F. Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res. 1991, 51, 794-798
22. Lim, S. D.; Sun, C.; Lambeth, J. D.; Marshall, F.; Amin, M.; Chung, L.; Petros, J. A.; Arnold, R. S. Increased nox1 and hydrogen peroxide in prostate cancer Prostate 2005, 62, 200-207 (Pubitemid 40096784)
23. Miguel, L.-L. Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy Cancer Lett. 2007, 252, 1-8
24. Yu, D. D.; Forman, B. M. Simple and efficient production of (Z)-4-hydroxytamoxifen, a potent estrogen receptor modulator J. Org. Chem. 2003, 68, 9489-9491 (Pubitemid 37456525)
25. Ishiyama, T.; Murata, M.; Miyaura, N. Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters J. Org. Chem. 1995, 60, 7508-7510
26. Thompson, A. L. S.; Kabalka, G. W.; Akula, M. R.; Huffman, J. W. The conversion of phenols to the corresponding aryl halides under mild conditions Synthesis 2005, 547-550 (Pubitemid 40396043)
27. Yuen, A. K. L.; Hutton, C. A. Deprotection of pinacolyl boronate esters via hydrolysis of intermediate potassium trifluoroborates Tetrahedron Lett. 2005, 46, 7899-7903 (Pubitemid 41455043)
28. McClaine, R. J.; Marshall, A. M.; Wagh, P. K.; Waltz, S. E. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines Neoplasia 2010, 12, 650-658